Flexion Therapeutics — Q4 2019 Earnings Presentation
7 slides from Flexion Therapeutics's earnings presentation, Mar 12, 2020
Slide 1: Commercial Metrics Overview
Commercial Metrics Overview March 12, 2020 Exhibit 99.2
Slide 2: Commercial Metrics Overview
Commercial Metrics Overview ZILRETTA® net sales of $23.7 million in the fourth quarter of 2019 We have called on almost all of our 4,972 target accounts 3,488 accounts have purchased ZILRETTA, as of December 31, 2019; up from 3,130, as of September 30, 2019 2,642 accounts have re-ordered ZILRETTA (7
Slide 3: ZILRETTA Net Sales Quarterly
ZILRETTA Net Sales Quarterly Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy
Slide 4: Distribution of Accounts by ZILRETTA Purchases Cumulative
Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors
Slide 5: Distribution of ZILRETTA Purchases by Accounts Cumulative
Distribution of ZILRETTA Purchases by Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors
Slide 6: ZILRETTA Purchases by New and Existing Accounts Cumulative
ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors
Slide 7: Flexion: Transformative Medicine... Where It Matters
clevion Transformative Medicine... Where It Matters